People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | — | Pharmaceuticals | Series B | $31.9M | $340.0M | 2019 |
PAUL MEDEIROS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PAUL MEDEIROS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nicholas Galakatos | 1 | 6 |
| Thomas Dyrberg | 1 | 5 |
| WILLIAM D. YOUNG | 1 | 4 |
| William Young | 1 | 3 |
| Stefan Vitorovic | 1 | 3 |
| Nicholas G. Galakatos | 1 | 2 |
| Alfred Sandrock | 1 | 2 |
| Stuart D. Chaffee | 1 | 1 |
| KIRAN REDDY | 1 | 1 |
| STUART CHAFFEE | 1 | 1 |
| ARI BRETTMAN | 1 | 1 |
| GREGORY NORDEN | 1 | 1 |
| Alfred G. Sandrock, Jr. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.